Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report
Identifieur interne : 003B47 ( Main/Exploration ); précédent : 003B46; suivant : 003B48Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report
Auteurs : Giovanni Cossu [Italie] ; Maurizio Melis [Italie] ; Giannina Melis [Italie] ; Elisabetta Maccioni [Italie] ; Valeria Putzu [Italie] ; Olga Catte [Italie] ; Paolo Francesco Putzu [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-10.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Alzheimer Disease (diagnosis), Alzheimer Disease (drug therapy), Alzheimer's disease, Botulinum Toxins, Type A (therapeutic use), Case study, Cholinesterase, Cholinesterase Inhibitors (adverse effects), Cholinesterase Inhibitors (therapeutic use), Cognition Disorders (diagnosis), Cognition Disorders (drug therapy), Dystonia (chemically induced), Dystonia (drug therapy), Dystonia (physiopathology), Female, Galantamine, Galantamine (adverse effects), Galantamine (therapeutic use), Humans, Nervous system diseases, Neuromuscular Agents (therapeutic use), Neuropsychological Tests, Pisa syndrome, Severity of Illness Index, Syndrome, galantamine.
- MESH :
- chemical , adverse effects : Cholinesterase Inhibitors, Galantamine.
- chemical , therapeutic use : Botulinum Toxins, Type A, Cholinesterase Inhibitors, Galantamine, Neuromuscular Agents.
- chemically induced : Dystonia.
- diagnosis : Alzheimer Disease, Cognition Disorders.
- drug therapy : Alzheimer Disease, Cognition Disorders, Dystonia.
- physiopathology : Dystonia.
- Aged, Female, Humans, Neuropsychological Tests, Severity of Illness Index, Syndrome.
Abstract
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type‐A injection. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20164
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003B34
- to stream Istex, to step Curation: 003B34
- to stream Istex, to step Checkpoint: 002528
- to stream PubMed, to step Corpus: 003307
- to stream PubMed, to step Curation: 003307
- to stream PubMed, to step Checkpoint: 003323
- to stream Ncbi, to step Merge: 000F81
- to stream Ncbi, to step Curation: 000F81
- to stream Ncbi, to step Checkpoint: 000F81
- to stream Main, to step Merge: 005505
- to stream PascalFrancis, to step Corpus: 002039
- to stream PascalFrancis, to step Curation: 000C82
- to stream PascalFrancis, to step Checkpoint: 002018
- to stream Main, to step Merge: 005856
- to stream Main, to step Curation: 003B47
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report</title><author><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name></author><author><name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name></author><author><name sortKey="Melis, Giannina" sort="Melis, Giannina" uniqKey="Melis G" first="Giannina" last="Melis">Giannina Melis</name></author><author><name sortKey="Maccioni, Elisabetta" sort="Maccioni, Elisabetta" uniqKey="Maccioni E" first="Elisabetta" last="Maccioni">Elisabetta Maccioni</name></author><author><name sortKey="Putzu, Valeria" sort="Putzu, Valeria" uniqKey="Putzu V" first="Valeria" last="Putzu">Valeria Putzu</name></author><author><name sortKey="Catte, Olga" sort="Catte, Olga" uniqKey="Catte O" first="Olga" last="Catte">Olga Catte</name></author><author><name sortKey="Putzu, Paolo Francesco" sort="Putzu, Paolo Francesco" uniqKey="Putzu P" first="Paolo Francesco" last="Putzu">Paolo Francesco Putzu</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:808912E2A5D80E5BB07ED42D3502EA916CE98D37</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1002/mds.20164</idno><idno type="url">https://api.istex.fr/document/808912E2A5D80E5BB07ED42D3502EA916CE98D37/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003B34</idno><idno type="wicri:Area/Istex/Curation">003B34</idno><idno type="wicri:Area/Istex/Checkpoint">002528</idno><idno type="wicri:doubleKey">0885-3185:2004:Cossu G:reversible:pisa:syndrome</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15389998</idno><idno type="wicri:Area/PubMed/Corpus">003307</idno><idno type="wicri:Area/PubMed/Curation">003307</idno><idno type="wicri:Area/PubMed/Checkpoint">003323</idno><idno type="wicri:Area/Ncbi/Merge">000F81</idno><idno type="wicri:Area/Ncbi/Curation">000F81</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F81</idno><idno type="wicri:doubleKey">0885-3185:2004:Cossu G:reversible:pisa:syndrome</idno><idno type="wicri:Area/Main/Merge">005505</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0581928</idno><idno type="wicri:Area/PascalFrancis/Corpus">002039</idno><idno type="wicri:Area/PascalFrancis/Curation">000C82</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002018</idno><idno type="wicri:doubleKey">0885-3185:2004:Cossu G:reversible:pisa:syndrome</idno><idno type="wicri:Area/Main/Merge">005856</idno><idno type="wicri:Area/Main/Curation">003B47</idno><idno type="wicri:Area/Main/Exploration">003B47</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report</title><author><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience A.O.B. “S. Michele” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience A.O.B. “S. Michele” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Melis, Giannina" sort="Melis, Giannina" uniqKey="Melis G" first="Giannina" last="Melis">Giannina Melis</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience A.O.B. “S. Michele” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Maccioni, Elisabetta" sort="Maccioni, Elisabetta" uniqKey="Maccioni E" first="Elisabetta" last="Maccioni">Elisabetta Maccioni</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Geriatry “SS. Trinità” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Putzu, Valeria" sort="Putzu, Valeria" uniqKey="Putzu V" first="Valeria" last="Putzu">Valeria Putzu</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Geriatry “SS. Trinità” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Catte, Olga" sort="Catte, Olga" uniqKey="Catte O" first="Olga" last="Catte">Olga Catte</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Geriatry “SS. Trinità” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author><author><name sortKey="Putzu, Paolo Francesco" sort="Putzu, Paolo Francesco" uniqKey="Putzu P" first="Paolo Francesco" last="Putzu">Paolo Francesco Putzu</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Geriatry “SS. Trinità” General Hospital Cagliari, Sardinia</wicri:regionArea><wicri:noRegion>Sardinia</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2004-10">2004-10</date><biblScope unit="vol">19</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1243">1243</biblScope><biblScope unit="page" to="1244">1244</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">808912E2A5D80E5BB07ED42D3502EA916CE98D37</idno><idno type="DOI">10.1002/mds.20164</idno><idno type="ArticleID">MDS20164</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Alzheimer Disease (diagnosis)</term><term>Alzheimer Disease (drug therapy)</term><term>Alzheimer's disease</term><term>Botulinum Toxins, Type A (therapeutic use)</term><term>Case study</term><term>Cholinesterase</term><term>Cholinesterase Inhibitors (adverse effects)</term><term>Cholinesterase Inhibitors (therapeutic use)</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (drug therapy)</term><term>Dystonia (chemically induced)</term><term>Dystonia (drug therapy)</term><term>Dystonia (physiopathology)</term><term>Female</term><term>Galantamine</term><term>Galantamine (adverse effects)</term><term>Galantamine (therapeutic use)</term><term>Humans</term><term>Nervous system diseases</term><term>Neuromuscular Agents (therapeutic use)</term><term>Neuropsychological Tests</term><term>Pisa syndrome</term><term>Severity of Illness Index</term><term>Syndrome</term><term>galantamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Cholinesterase Inhibitors</term><term>Galantamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term><term>Cholinesterase Inhibitors</term><term>Galantamine</term><term>Neuromuscular Agents</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Dystonia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Alzheimer Disease</term><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Alzheimer Disease</term><term>Cognition Disorders</term><term>Dystonia</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Dystonia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Neuropsychological Tests</term><term>Severity of Illness Index</term><term>Syndrome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cholinesterase</term><term>Etude cas</term><term>Galantamine</term><term>Système nerveux pathologie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type‐A injection. © 2004 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Cossu, Giovanni" sort="Cossu, Giovanni" uniqKey="Cossu G" first="Giovanni" last="Cossu">Giovanni Cossu</name></noRegion><name sortKey="Catte, Olga" sort="Catte, Olga" uniqKey="Catte O" first="Olga" last="Catte">Olga Catte</name><name sortKey="Maccioni, Elisabetta" sort="Maccioni, Elisabetta" uniqKey="Maccioni E" first="Elisabetta" last="Maccioni">Elisabetta Maccioni</name><name sortKey="Melis, Giannina" sort="Melis, Giannina" uniqKey="Melis G" first="Giannina" last="Melis">Giannina Melis</name><name sortKey="Melis, Maurizio" sort="Melis, Maurizio" uniqKey="Melis M" first="Maurizio" last="Melis">Maurizio Melis</name><name sortKey="Putzu, Paolo Francesco" sort="Putzu, Paolo Francesco" uniqKey="Putzu P" first="Paolo Francesco" last="Putzu">Paolo Francesco Putzu</name><name sortKey="Putzu, Valeria" sort="Putzu, Valeria" uniqKey="Putzu V" first="Valeria" last="Putzu">Valeria Putzu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:808912E2A5D80E5BB07ED42D3502EA916CE98D37
|texte= Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report
}}
| This area was generated with Dilib version V0.6.23. |  |